BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36934658)

  • 1. Are neurologic symptoms associated with worse QoL in non-CNS cancer patients?
    Cacho-Díaz B; González-González E; Mauricio Bonilla-Navarrete A; Texcocano-Becerra J; Oñate-Ocaña LF
    J Clin Neurosci; 2023 May; 111():39-45. PubMed ID: 36934658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Content validation of the EORTC QLQ-C15-PAL with advanced cancer patients and health care professionals from palliative care services in Chile.
    Rojas-Concha L; Hansen MB; Petersen MA; Groenvold M
    BMC Palliat Care; 2020 Jun; 19(1):81. PubMed ID: 32517678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of radiotherapy on quality of life for cancer patients: a longitudinal study.
    Yucel B; Akkaş EA; Okur Y; Eren AA; Eren MF; Karapinar H; Babacan NA; Kiliçkap S
    Support Care Cancer; 2014 Sep; 22(9):2479-87. PubMed ID: 24728584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
    Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients.
    Zahid N; Martins RS; Zahid W; Khalid W; Azam I; Bhamani SS; Asad N; Ahmad K; Jabbar AA; Shamim MS; Khan RJ; Javed G; Bari E; Enam SA
    J Patient Rep Outcomes; 2021 Sep; 5(1):79. PubMed ID: 34487251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30.
    Chiu L; Chiu N; Zeng L; Zhang L; Popovic M; Chow R; Lam H; Poon M; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):831-7. PubMed ID: 23252363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients.
    Hinz A; Mehnert A; Dégi C; Reissmann DR; Schotte D; Schulte T
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26568527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
    Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
    J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor-naive ALK + non-small cell lung cancer (ALTA-1L).
    Garcia Campelo MR; Lin HM; Zhu Y; Pérol M; Jahanzeb M; Popat S; Zhang P; Camidge DR
    Lung Cancer; 2021 May; 155():68-77. PubMed ID: 33744781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
    Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
    J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-Sectional Patient-Reported Outcome Measuring of Health-Related Quality of Life With Establishment of Cancer- and Treatment-Specific Functional and Symptom Scales in Patients With Penile Cancer.
    Draeger DL; Sievert KD; Hakenberg OW
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1215-e1220. PubMed ID: 30201215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Content verification of the EORTC QLQ-C30/EORTC QLQ-BR23 with the International Classification of Functioning, Disability and Health.
    Letellier ME; Dawes D; Mayo N
    Qual Life Res; 2015 Mar; 24(3):757-68. PubMed ID: 25150708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study.
    Machingura A; Taye M; Musoro J; Ringash J; Pe M; Coens C; Martinelli F; Tu D; Basch E; Brandberg Y; Grønvold M; Eggermont A; Cardoso F; Van Meerbeeck J; van der Graaf WTA; Taphoorn M; Reijneveld JC; Soffietti R; Sloan J; Velikova G; Flechtner H; Bottomley A;
    Eur J Cancer; 2022 Jul; 170():1-9. PubMed ID: 35569438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials.
    Koller M; Musoro JZ; Tomaszewski K; Coens C; King MT; Sprangers MAG; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A
    Lung Cancer; 2022 May; 167():65-72. PubMed ID: 35413526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-of-life impairment after endoluminal locoregional resection and laparoscopic total mesorectal excision.
    Lezoche E; Paganini AM; Fabiani B; Balla A; Vestri A; Pescatori L; Scoglio D; D'Ambrosio G; Lezoche G
    Surg Endosc; 2014 Jan; 28(1):227-34. PubMed ID: 24002918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.
    King MT; Costa DS; Aaronson NK; Brazier JE; Cella DF; Fayers PM; Grimison P; Janda M; Kemmler G; Norman R; Pickard AS; Rowen D; Velikova G; Young TA; Viney R
    Qual Life Res; 2016 Mar; 25(3):625-36. PubMed ID: 26790428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia.
    Imran M; Al-Wassia R; Alkhayyat SS; Baig M; Al-Saati BA
    PLoS One; 2019; 14(7):e0219093. PubMed ID: 31291302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of AC and AC-T Chemotherapy's Toxicities on Quality of Life Among Women with Breast Cancer in Ethiopia: A Prospective Patient-Reported Outcomes Study.
    Gadisa DA; Wang SH; Yimer G
    Breast Cancer (Dove Med Press); 2021; 13():107-132. PubMed ID: 33658844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.